Ocumetics Technology Corp.

DB:2QB0 Stock Report

Market Cap: €30.1m

Ocumetics Technology Past Earnings Performance

Past criteria checks 0/6

Ocumetics Technology's earnings have been declining at an average annual rate of -36.2%, while the Medical Equipment industry saw earnings declining at 1.1% annually.

Key information

-36.2%

Earnings growth rate

-23.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Ocumetics Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:2QB0 Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-321
31 Mar 240-431
31 Dec 230-431
30 Sep 230-331
30 Jun 230-321
31 Mar 230-221
31 Dec 220-211
31 Dec 210-420
31 Jul 210-110
30 Apr 210000
31 Jul 200000
31 Jul 190000

Quality Earnings: 2QB0 is currently unprofitable.

Growing Profit Margin: 2QB0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2QB0 is unprofitable, and losses have increased over the past 5 years at a rate of 36.2% per year.

Accelerating Growth: Unable to compare 2QB0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2QB0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: 2QB0's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies